IL207631A0 - Postsynaptically targeted chemodenervation agents and their methods of use - Google Patents

Postsynaptically targeted chemodenervation agents and their methods of use

Info

Publication number
IL207631A0
IL207631A0 IL207631A IL20763110A IL207631A0 IL 207631 A0 IL207631 A0 IL 207631A0 IL 207631 A IL207631 A IL 207631A IL 20763110 A IL20763110 A IL 20763110A IL 207631 A0 IL207631 A0 IL 207631A0
Authority
IL
Israel
Prior art keywords
methods
postsynaptically targeted
targeted chemodenervation
agents
chemodenervation agents
Prior art date
Application number
IL207631A
Other languages
English (en)
Original Assignee
Myocept Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Myocept Inc filed Critical Myocept Inc
Publication of IL207631A0 publication Critical patent/IL207631A0/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Genetics & Genomics (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biophysics (AREA)
  • Biomedical Technology (AREA)
  • Dermatology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Medicinal Preparation (AREA)
IL207631A 2008-02-19 2010-08-16 Postsynaptically targeted chemodenervation agents and their methods of use IL207631A0 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US6634708P 2008-02-19 2008-02-19
PCT/US2009/034578 WO2009105585A2 (en) 2008-02-19 2009-02-19 Postsynaptically targeted chemodenervation agents and their methods of use

Publications (1)

Publication Number Publication Date
IL207631A0 true IL207631A0 (en) 2010-12-30

Family

ID=40986187

Family Applications (1)

Application Number Title Priority Date Filing Date
IL207631A IL207631A0 (en) 2008-02-19 2010-08-16 Postsynaptically targeted chemodenervation agents and their methods of use

Country Status (9)

Country Link
US (1) US9815875B2 (enExample)
EP (1) EP2250193B1 (enExample)
JP (1) JP2011523935A (enExample)
CN (1) CN102007142A (enExample)
AU (1) AU2009215436A1 (enExample)
CA (1) CA2754352A1 (enExample)
ES (1) ES2757648T3 (enExample)
IL (1) IL207631A0 (enExample)
WO (1) WO2009105585A2 (enExample)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7259237B1 (en) 2006-12-29 2007-08-21 Miller Kent D Pan-antiviral peptides
TWI558398B (zh) 2009-09-22 2016-11-21 諾華公司 菸鹼乙醯膽鹼受體α７活化劑之用途
US20120302492A1 (en) * 2009-10-30 2012-11-29 Bayer Healthcare Llc Antibody Mimetic Scaffolds
US9220743B2 (en) * 2010-01-22 2015-12-29 Nuovo Biologics, Llc Pan-antiviral peptides for protein kinase inhibition
CN103145799B (zh) * 2013-02-18 2014-04-16 大连理工大学 一组具有促进经皮和跨膜渗透作用的多肽及其应用
CN104232653B (zh) * 2014-09-19 2017-04-05 中南大学湘雅医院 重组α‑银环蛇毒素αBtx的制备方法
KR20190137781A (ko) * 2017-02-07 2019-12-11 마이오셉트 인코포레이티드 국소 제제 및 방법
CN110090296A (zh) * 2018-09-21 2019-08-06 祁展楷 一组与烟碱乙酰胆碱受体具有高度亲和力能快速起效的眼镜蛇神经毒素分子在镇痛上的应用
EP3866828A4 (en) 2018-10-16 2022-08-31 GLO Pharma, Inc. Nicotinic acetylcholine receptor peptide antagonist conotoxin compositions and related methods
CA3124195A1 (en) * 2018-12-21 2020-06-25 Vib Vzw Fusion protein with a toxin and scaffold protein
EP3753568A1 (en) * 2019-06-21 2020-12-23 Fastox Pharma SA Composition modulating botulinum neurotoxin effect
CN110478473B (zh) * 2019-07-14 2025-08-12 江苏毫末医药生物科技有限公司 眼镜蛇神经毒素多肽对鸦片类药品痛觉过敏和耐受的抑制及对其镇痛的协同增效作用
WO2021068432A1 (zh) * 2019-10-11 2021-04-15 祁展楷 眼镜蛇科蛇突触后神经毒素单体分子在治疗老年痴呆上的应用
US20230062487A1 (en) * 2020-01-24 2023-03-02 W. L. Gore & Associates, Inc. Sustained-release matrices for adventitial or periadventitial neural ablation and uses thereof
CN111544571A (zh) * 2020-06-02 2020-08-18 沈喆景 眼镜蛇科蛇突触后神经毒素在治疗与炎性细胞因子过度表达相关疾病的应用
CN114409757B (zh) * 2022-01-26 2023-07-18 云南南诏药业有限公司 一种蛇毒神经毒素及应用

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4447356A (en) 1981-04-17 1984-05-08 Olivera Baldomero M Conotoxins
FR2762009B1 (fr) * 1997-04-10 1999-06-04 Commissariat Energie Atomique Enzymes recombinantes purifiees a activite prolylpeptidasique, leur procede de preparation et leurs applications
IL143379A (en) * 2001-05-24 2013-11-28 Yissum Res Dev Co Oligonucleotide against human ache isoform r and its uses
ES2345667T3 (es) 2004-11-02 2010-09-29 Dsm Ip Assets B.V. Nuevos principios activos de aplicacion topica contra las arrugas de expresion y las relacionadas con la edad.
US7659252B2 (en) * 2005-09-15 2010-02-09 Novomed Technologies, Inc. (Shanghai) Transdermal delivery peptides and method of use thereof
WO2007035474A2 (en) * 2005-09-15 2007-03-29 Novomed Technologies, Inc. (Shanghai) Transdermal delivery peptides and method of use thereof

Also Published As

Publication number Publication date
US9815875B2 (en) 2017-11-14
EP2250193B1 (en) 2019-09-18
AU2009215436A1 (en) 2009-08-27
WO2009105585A2 (en) 2009-08-27
US20110118190A1 (en) 2011-05-19
CN102007142A (zh) 2011-04-06
ES2757648T3 (es) 2020-04-29
JP2011523935A (ja) 2011-08-25
CA2754352A1 (en) 2009-08-27
EP2250193A2 (en) 2010-11-17
WO2009105585A3 (en) 2009-12-23

Similar Documents

Publication Publication Date Title
IL207631A0 (en) Postsynaptically targeted chemodenervation agents and their methods of use
IL275881B (en) Methods for using alpha1–il antibodies
IL209754A0 (en) Diazacarbazoles and methods of use
IL210221A0 (en) Notch-binding agents and antagonists and methods of use thereof
IL213547A0 (en) Compounds and methods of use
EP2340244A4 (en) COMPOUNDS AND APPLICATION PROCEDURES
ZA201003625B (en) 5-anilinoimidazopyridines and methods of use
EP2262450A4 (en) IMPLANTS AND METHODS OF USE
ZA201101119B (en) Pd-1 antagonists and methods of use thereof
ZA201102076B (en) Herbicide-resistant ahas-mutants and methods of use
ZA201104467B (en) Heterocyclic compounds and methods of use
SI2320911T1 (sl) Vazokonstrikcijski sestavki in metode uporabe
ZA201008713B (en) Antimicrobial compositions and methods of use
IL210582A0 (en) Deuterated benzylbenzene derivatives and methods of use
PL2346327T3 (pl) Kompozycje biobójcze i sposoby stosowania
IL209548A0 (en) Diazacarbazoles and methods of use
EP2288365A4 (en) TARGETED COOLING FACTORS AND METHOD OF APPLICATION THEREFOR
EP2326171A4 (en) ANTIMICROBIAL COMPOSITIONS AND METHODS OF USE
IL206125A0 (en) Azaindolizines and methods of use
EP2242854A4 (en) COMPOUNDS AND USES THEREOF
IL236830A0 (en) Diazahomoredene derivatives and methods of using them
ZA201007129B (en) Limk2 inhibitors,compositions comprising them,and methods of their use
EP2231665A4 (en) NEW COMPOSITIONS AND METHODS OF USE
EP2421542A4 (en) SPUME VIRUS VECTORS AND METHODS OF USE
ZA201104722B (en) Animal treatment formulation and methods of use